Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)
NCT03232203
·
clinicaltrials.gov ↗
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Severe Combined Immunodeficiency Due to ADA Deficiency
Interventions
DRUG:
STRIMVELIS
Sponsor
Fondazione Telethon